Novozymes A/S (CPH:NSIS.B)
Denmark flag Denmark · Delayed Price · Currency is DKK
378.00
-2.60 (-0.68%)
At close: Apr 28, 2026

Novozymes Revenue

In the year 2025, Novozymes had annual revenue of 4.16B EUR with 8.45% growth. Novozymes had revenue of 996.60M in the quarter ending December 31, 2025, with 1.55% growth.

Revenue
4.16B EUR
Revenue Growth
+8.45%
P/S Ratio
5.67
Revenue / Employee
369.14K EUR
Employees
11,263
Market Cap
176.12B DKK

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20254.16B324.10M8.45%
Dec 31, 20243.83B1.43B59.58%
Dec 31, 20232.40B42.38M1.80%
Dec 31, 20222.36B348.99M17.36%
Dec 31, 20212.01B128.32M6.82%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Vestas Wind Systems 140.57B
A.P. Møller - Mærsk 343.41B
Ørsted 73.24B
Danske Bank 56.55B
Carlsberg 89.10B
Genmab 23.66B
Coloplast 27.89B
Tryg A/S 43.23B
Revenue Rankings

Novozymes News

More News